MuscleBlaze Secures U.S. Patent to Power Global Expansion of Enzyme-Enhanced Protein Range
- PYD
- Mar 22
- 2 min read
Indian sports nutrition leader MuscleBlaze is accelerating international growth following its newly granted U.S. patent for an enzyme blend that enhances protein absorption. With credibility boosted and regulatory clarity in place, the brand is prioritising expansion across Southeast Asia, the Middle East, and key Western markets.
Insights & Strategic Moves:
U.S. Patent Secured for Biozyme Innovation:
MuscleBlaze obtained a U.S. invention patent (Feb 2025) for a proprietary blend of proteolytic enzymes—sourced from fruits and microbes—that enhances branched-chain amino acid (BCAA) bioavailability by up to 60%. This blend powers the brand’s flagship Biozyme Whey (MB EnzymePro) product, already awarded Sports Nutrition Product of the Year 2021 by NutraIngredients-Asia.
International Expansion Targets SEA and Gulf Markets First
Armed with U.S. patent protection, MuscleBlaze is doubling down on its “digital-first” international strategy, focusing first on Southeast Asia (Singapore, Malaysia, Thailand, Indonesia) and GCC markets (Dubai, Saudi Arabia), where geographical proximity supports operational efficiency.
U.S. and Australia as Secondary Focus Regions:
The brand is re-entering the U.S. market, especially West Coast states like California, post-COVID with a refined strategy. Australia is also on the roadmap for near-term entry, driven by rising demand for clean-label, certified sports nutrition products.
Third-Party Certifications Build Trust in Domestic and Export Markets:
In addition to the U.S. patent, MuscleBlaze holds UK’s Informed Choice and U.S. Informed Protein Certifications, now prominently displayed on packaging. These certifications are essential for consumer trust in counterfeit-sensitive markets like India and emerging SEA markets.
Counterfeit-Proofing Through Innovation:
To combat protein spiking and fake products, the brand introduced a consumer test kit that verifies whey content in real time. Since its launch, this initiative has driven a 10% market share gain in India’s protein category by helping consumers detect quality and avoid fraud.
Domestic Pricing Pressure Drives Focus on Authenticity:
With raw material costs pushing retail prices up by 15–20%, counterfeit risk has increased. The company anticipates rising demand for scientifically validated, traceable products, reinforcing the relevance of its patent-backed and certified portfolio.
Forward Outlook:
MuscleBlaze’s patent-backed Biozyme range provides a clear technical edge in crowded protein markets. Its focus on transparency, testing, and international certifications positions the brand for premiumisation across both domestic and global sports nutrition channels.
By aligning innovation, certification, and go-to-market precision, MuscleBlaze is emerging as a credible global challenger in the sports nutrition space—starting with Southeast Asia, but with eyes firmly set on the U.S.
Comments